This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The incidence of chronic myeloid leukaemia (CML) is around 1–2 cases per 100 000 population/year without an obvious geographical difference (1).

  • in England and Wales
  • CML accounts for more than one in six leukaemias in adults with around 600 new cases being registered each year
  • the annual case rates are 1.0 per 100,000 men and 0.8 per 100,000 women
  • around 2660 people have CML (2)
  • accounts for 15-20% of cases of leukaemias in developed countries
  • the incidence increases with age (3), median age at diagnosis is around 65 years (4)
  • it affects men more than women and there seems to be a survival advantage in women over men (4)
  • chronic granulocytic leukaemia is the most common variant of CML

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.